SEC Form D filing
Angiocrine Bioscience, Inc., 2025-09-05
An SEC Form D private-offering notice from San Diego, CA, a $3,000,000 filer-stated offering target. Filed 2025-09-05. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Angiocrine Bioscience, Inc. Verified via SEC Form D
Filed 2025-09-05Filed to raise $3,000,000First money in 2025-08-21Raised so far $2,100,000HQ (as filed) San Diego, CAStage (inferred) Seed
Source linked the Form D on EDGAR↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- DuetsAI, inc., 2025-09-05, $20K, San Francisco, CA
- Assumable Technologies Inc., 2025-09-05, $1.5M, San Diego, CA
- Pylon Labs, Inc., 2025-09-05, $31.5M, San Francisco, CA
- Avenzo Therapeutics, Inc., 2025-09-05, $75M, San Diego, CA
- Aervivo, Inc., 2025-09-05, $2.2M, San Diego, CA
- Elea.ai, Inc, 2025-09-04, $10.6M, Menlo Park, CA
- First Andes Silver Ltd., 2025-09-05, $13K, Vancouver, BC, Canada
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.